BPG is committed to discovery and dissemination of knowledge
Articles in Press
9/8/2025 10:49:14 AM | Browse: 23 | Download: 5
Category |
Cardiac & Cardiovascular Systems |
Manuscript Type |
Basic Study |
Article Title |
Mesenchymal stem-derived exosomes enhance therapeutic benefits of exercise in isoproterenol-induced myocardial ischemia: Targeting ERK and Akt/mTOR signaling
|
Manuscript Source |
Invited Manuscript |
All Author List |
Asmaa M ShamsEldeen, Manar M AbdElalim, Nahed S Mohamed, Marwa M AbdelRahman, Samaa S Kamar, Dina H AbdelKader, Samar H Elsharkawy, Laila A Rashed, Salwa S Faisal, Walla’a A Osman and Asmaa M Selmy |
Funding Agency and Grant Number |
|
Corresponding Author |
Asmaa M ShamsEldeen, Assistant Professor, MD, Department of Physiology, Cairo University, Al-Saray Street, El Manial, Cairo 30411, Egypt. asmaa82shamseldeen@gmail.com |
Key Words |
Myocardial infarction; Exercise; Exosomes; Sarcoplasmic endoplasmic reticulum calcium ATPase type 2; Extracellular signal-regulated kinase 1/2; Cardiac hypertrophy; Ejection fraction |
Core Tip |
Myocardial infarction has been extensively validated in rats for reliably inducing post-infarction metabolic and histological changes. Combined therapy may target the extracellular signal-regulated kinase and protein kinase B/mammalian target of rapamycin signaling, both of which are central to the development of hypertrophic remodeling after myocardial infarction, along with the crosstalk between matrix metalloproteinase 9 and sarcoplasmic endoplasmic reticulum calcium ATPase type 2a, which maintains the balance between hypertrophic growth and contractile function. This could offer a new therapeutic regimen for treating early maladaptive left ventricular hypertrophy. |
Citation |
ShamsEldeen AM, AbdElalim MM, Mohamed NS, AbdelRahman MM, Kamar SS, AbdelKader DH, Elsharkawy SH, Rashed LA, Faisal SS, Osman WA, Selmy AM. Mesenchymal stem-derived exosomes enhance therapeutic benefits of exercise in isoproterenol-induced myocardial ischemia: Targeting ERK and Akt/mTOR signaling. World J Stem Cells 2025; In press |
 |
Received |
|
2025-05-26 13:39 |
 |
Peer-Review Started |
|
2025-05-26 13:39 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-06-07 05:51 |
 |
Revised |
|
2025-06-19 22:29 |
 |
Second Decision |
|
2025-09-01 00:38 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-09-08 10:49 |
 |
Articles in Press |
|
2025-09-08 10:49 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
1948-0210 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345